MAPS’ MDMA/PTSD research team met in Charleston, South Carolina to review the forms and procedures that will be used to conduct the study. The meeting went extremely well. Amy and Todd, the clinical research monitors who are volunteering to help us implement pharmaceutical-level monitoring and checks and balances, were impressively professional. This study will be conducted with a level of formality and oversight that MAPS is implementing for the first time but that will become standard on all our MDMA research projects.